Home > Insider Trading > Filing (0001562180-21-002904)

Filing Details

Accession Number:: 0001562180-21-002904
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-21 21:19:30
Reporting Period:: 2021-04-19

Accepted Time:: 2021-04-21 21:19:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1603756	Axonics Inc.	AXNX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1359446	Jr J Alfred Ford	26 Technology Drive Irvine CA 92618	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-04-19	14,871	$1.42	28,595	No	4	M	Direct
Common Stock	Acquisiton	2021-04-19	5,721	$1.63	34,316	No	4	M	Direct
Common Stock	Acquisiton	2021-04-19	19,258	$14.19	53,574	No	4	M	Direct
Common Stock	Acquisiton	2021-04-19	6,347	$25.82	59,921	No	4	M	Direct
Common Stock	Disposition	2021-04-19	41,794	$58.33	18,127	No	4	S	Direct
Common Stock	Disposition	2021-04-19	12,502	$59.33	5,625	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-19	6,347	$0.00	6,347	$25.82
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-19	19,258	$0.00	19,258	$14.19
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-19	5,721	$0.00	5,721	$1.63
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-19	14,871	$0.00	14,871	$1.42

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,965	2029-12-12	No	4	M	Direct
16,297	2029-01-30	No	4	M	Direct
1,899	2028-03-30	No	4	M	Direct
8,509	2027-11-15	No	4	M	Direct

Footnotes

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan
This transaction was executed in multiple trades at prices ranging from $57.87 to $58.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.87 to $59.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on November 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of November 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.